Norwegian bank DnB Nor has gone live with what is believed
to be the first contactless mobile payment service in the
country’s capital Oslo.
The bank has partnered with mobile network operator Telenor and
issued 250 Samsung S5230 handsets which support near field
communications technology (NFC) to Telenor’s customers.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataDnB Nor and Telenor have been collaborating on NFC services
since 2008.
But the bank only just rolled out the Tap2Pay pilot service now
as part of a user-driven research programme partly financed by the
research council of Norway.
The trial takes place across several retail stores,
but is mostly focused on the Norwegian version of coffee-chain
Starbucks, Kaffebrenneriet.
“real customers in real life settings”
The trial is the first to use “real customers in real life
settings”, the head of payment & enabling at Telenor Norway,
Viktoria Erngard, said.
DnB Nor’s CEO Rune Bjerke said that the bank targeted a
leadership role in digital banking services.
“The test will show how we can work together [with Telenor] to
bring the payment systems of the future to Norway,” he said.
NFC is the future
It will take years for NFC mobile payments to take off as the
market is still in its infancy because NFC-enabled handsets are
rare and consumers need to adopt the channel as a regular payments
method.
But DnB Nor and Telenor expect NFC mobile payments to be the
future of payments.
MasterCard, merchant acquirer teller, payments solutions
provider Nets as well as NFC technology provider Giesecker &
Devrient are also partaking in the trial.